Literature DB >> 19562441

Crush syndrome due to drug-induced compartment syndrome: a rare condition not to be overlooked.

Markus Golling1, Hamidreza Fonouni, Arianeb Mehrabi, Nicholas McArthur, Franz-Xaver Huber.   

Abstract

PURPOSE: The crush syndrome caused by drug-induced compartment syndrome (DCS) is a challenge for surgeons because it is regularly associated with potentially fatal complications. Drug-induced compartment syndrome can often be distinguished from other forms of compartment syndrome by the presence of severe rhabdomyolysis with kidney crush and severe postoperative complications such as local and generalized infection, persistent nerve damage, coagulopathy, and multiorgan failure.
METHODS: In the past 15 years, eight prospectively documented, operatively managed, DCS with subsequent crush syndrome cases were recorded.
RESULTS: All of the patients required renal replacement therapy. The creatine kinase (CK) values in the context of rhabdomyolysis reached an average of 86 (range 47-144) kU/l. The renal function recovered in all surviving patients. The analysis showed that the diagnosis of a DCS is usually made after an average of 13 h. It then took an average of an additional 7 h before a fasciotomy was performed. Six operational revisions were necessary. In three out of eight patients the extremities had to be amputated.
CONCLUSIONS: In DCS the decision to open the compartment should be made immediately upon the clinical diagnosis. A protracted intensive phase is expected. The benefit to patients is closely associated with surgical wound debridement along with rigorous intensive therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19562441     DOI: 10.1007/s00595-009-3928-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  44 in total

Review 1.  The crush syndrome revisited (1940-1990).

Authors:  O S Better
Journal:  Nephron       Date:  1990       Impact factor: 2.847

2.  Drugs, coma, and myoglobinuria.

Authors:  A S Penn; L P Rowland; D W Fraser
Journal:  Arch Neurol       Date:  1972-04

3.  Crush injury to the lower limbs. Treatment of the local injury.

Authors:  N D Reis; M Michaelson
Journal:  J Bone Joint Surg Am       Date:  1986-03       Impact factor: 5.284

4.  Long-term physical outcome of patients who suffered crush syndrome after the 1995 Hanshin-Awaji earthquake: prognostic indicators in retrospect.

Authors:  Tetsuya Matsuoka; Toshiharu Yoshioka; Hiroshi Tanaka; Norihisa Ninomiya; Jun Oda; Hisashi Sugimoto; Junichiro Yokota
Journal:  J Trauma       Date:  2002-01

5.  Crush syndrome due to limb compression.

Authors:  M J Kikta; J P Meyer; R A Bishara; S F Goodson; J J Schuler; P Flanigan
Journal:  Arch Surg       Date:  1987-09

Review 6.  Acute complications of extremity trauma.

Authors:  Edward J Newton; John Love
Journal:  Emerg Med Clin North Am       Date:  2007-08       Impact factor: 2.264

Review 7.  Crush injury and rhabdomyolysis.

Authors:  Darren J Malinoski; Matthew S Slater; Richard J Mullins
Journal:  Crit Care Clin       Date:  2004-01       Impact factor: 3.598

Review 8.  Crush injury and crush syndrome: a review.

Authors:  Jason Smith; Ian Greaves
Journal:  J Trauma       Date:  2003-05

9.  Intramuscular pressures with limb compression. Clarification of the pathogenesis of the drug-induced muscle-compartment syndrome.

Authors:  C A Owen; S J Mubarak; A R Hargens; L Rutherford; L P Garetto; W H Akeson
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

10.  [Plexus lesions, rhabdomyolysis and heroin].

Authors:  E Hecker; W G Friedli
Journal:  Schweiz Med Wochenschr       Date:  1988-12-31
View more
  2 in total

1.  Current status of and prospects for the English medical journal Surgery Today.

Authors:  Yoshihiko Maehara; Yoshihiro Kakeji
Journal:  Surg Today       Date:  2010-12       Impact factor: 2.549

2.  Case files of the medical toxicology fellowship at Drexel University. Rhabdomyolysis and compartment syndrome following acute diphenhydramine overdose.

Authors:  David Vearrier; John A Curtis
Journal:  J Med Toxicol       Date:  2011-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.